Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Analyst Predicts Bitcoin Boom Due to U.S. Debt, Money Debasement, and Global Trends
  2. Bitcoin ($BTC) Price to Rise to $30,000 in Second Half of 2023, VanEck Says
  3. Church & Dwight Down 6% As Outlook Comes In Lower Than Estimates
  4. Insignia Systems Shares Rise In Morning Trade
  5. MicroStrategy Splurges $150 Million On Bitcoin, Repays $205 Million Silvergate Loan At 22% Discount